A social preference valuations set for EQ-5D health states in Flanders, Belgium

European Journal of Health Economics

Volumn 11, Issue 2, 2010, Pages 205-213

  Cleemput, Irina ^a  

^a NONE

Author keywords

Cost utility analysis; EQ 5D; EuroQol; Quality of life; Value set

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; BELGIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECONOMIC EVALUATION; EUROQOL 5 DIMENSION; FEMALE; HEALTH ECONOMICS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW ZEALAND; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION; VISUAL ANALOG SCALE;

ADULT; BELGIUM; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; PAIN MEASUREMENT; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REFERENCE VALUES; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE; SOCIAL VALUES;

EID: 77954887570     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-009-0167-0     Document Type: Article

References (30)

1. Dolan, P.: Modeling valuations for EuroQol health states. Med Care 35, 1095-1108 (1997)
2. MVH Group: The measurement and valuation of health. Final report on the modelling of valuation tariffs. York Centre for Health Economics (1995)
3. Greiner, W., Claes, C., van Busschbach, J., Graf von der Schulenburg, J.: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6, 124-130 (2005)
4. Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., Tamura, M.: Estimating an EQ-5D population value set: the case of Japan. Health Econ 11, 341-353 (2002)
5. Wittrup-Jensen, K.U., Lauridsen, J.T., Gudex, C., Brooks, R., Pedersen, K.M.: Estimating Danish EQ-5D tariffs using TTO and VAS. In: Norinder, A., Pedersen, K., Roos, P. (eds.) 18th Plenary Meeting of the EuroQol Group, pp. 257-292 IHE, The Swedish Institute for Health Economics (2002)
6. Lamers, L.M., McDonnell, J., Stalmeier, P., Krabbe, P., Busschbach, J.: The Dutch Tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 15, 1121-1132 (2006)
7. Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43, 203-220 (2005)
8. Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul Health Metrics 1, 11 (2003)
9. Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21, 7-16 (2001)
10. Claes, C., Greiner, W., Uber, A., Graf von der Schulenburg, J.: An interview-based comparison of the TTO and VAS values given to EuroQol states of health by the general German population. In: Greiner, W., Graf von der Schulenburg, J., Piercy, J. (eds.) EQ Plenary Meeting. Hannover (1999)
11. Ohinmaa, A., Eija, H., Sintonen, H.: Modelling EuroQol values of Finnish adult population. In: Badia, X., Herdman, M., Segura, A., (eds.) EuroQol Plenary Meeting. Barcelona. Institut Universitari de Salut Publica de Catalunya (1995)
12. Ohinmaa, A., Sintonen, H.: Inconsistencies and modelling of the Finnish EuroQol (EQ-5D) preference values. Paper presented for the 15th EuroQol Plenary Meeting, Hanover (1998)
13. Devlin, N.J., Hansen, P., Kind, P., Williams, A.: Logical inconsistencies in survey respondents' health state valuations-a methodological challenge for estimating social tariffs. Health Econ 12, 529-544 (2003)
14. Prevolnik Rupel, V., Rebolj, M.: The Slovenian VAS Tariff based on valuations of EQ-5D health states from the general population. In: Cabasés, J.M., Gaminde, I. (eds.) 17th Plenary Meeting of the EuroQol Group, pp. 23-47. Universidad Pública de Navarra (2001)
15. Badia, X., Roset, M., Monserrat, S., Herdman, M.: The Spanish VAS tariff based on valuations of EQ-5D health states from the general population. Proceedings of the EuroQol Plenary Meeting, Rotterdam (1997)
16. Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., Buxton, M., Dolan, P., Kind, P., Krabbe, P., Ohinmaa, A., Parkin, D., Roset, M., Sintonen, H., Tsuchiya, A., de Charro, F.: A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4, 222-231 (2003)
17. Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets: inventory. Comparative Review and User Guide. Springer, Dordrecht (2007)
18. Gudex, C., Dolan, P., Kind, P., Williams, A.: Health state valuations from the general public using the visual analogue scale. Qual Life Res 5, 521-531 (1996)
19. Nord, E.: EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 18, 25-36 (1991)
20. Brooks, R., Jendteg, S., Lindgren, B., Persson, U., Björk, S.: EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 18, 37-48 (1991)
21. van Agt, H.M., Essink-Bot, M.L., Krabbe, P.F., Bonsel, G.J.: Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1982) 39, 1537-1544 (1994)
22. Badia, X., Fernandez, E., Segura, A.: Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Pub Health 5, 87-93 (1995)
23. Kind, P., Dolan, P., Gudex, C., Williams, A.: Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 316, 736-741 (1998)
24. Dolan, P., Kind, P.: Inconsistency and health state valuations. Soc Sci Med 42, 609-615 (1996)
25. O'Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5-389 (1994)
26. Gudex, C., Dolan, P.: Valuing health states: the effect of duration. Discussion Paper (1995)
27. Dolan, P.: The effect of experience of illness on health state valuations. J Clin Epidemiol 49, 551-564 (1996) (Pubitemid 26195611)
28. Badia, X., Monserrat, S., Roset, M., Herdman, M.: Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 8, 303-310 (1999)
29. Cleemput, I., Van Wilder, P., Vrijens, F., Huybrechts, M., Ramaekers, D.: Guidelines for Pharmacoeconomic Evaluations in Belgium. KCE Reports. Belgian Health Care Knowledge Centre (KCE), Bruxelles (2008)
30. Cleemput, I., van Wilder, P., Huybrechts, M., Vrijens, F.: Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests. Value Health 2008; Early View (2008)